Authors:
Reddy, KR
Wright, TL
Pockros, PJ
Shiffman, M
Everson, G
Reindollar, R
Fried, MW
Purdum, PP
Jensen, D
Smith, C
Lee, WM
Boyer, TD
Lin, A
Pedder, S
DePamphilis, J
Citation: Kr. Reddy et al., Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared withinterferon alpha-2a in noncirrhotic patients with chronic hepatitis C, HEPATOLOGY, 33(2), 2001, pp. 433-438
Authors:
McHutchison, JG
Ponnudurai, R
Bylund, DL
Anguiano, A
Pockros, PJ
Mondala, T
Wilkes, LB
Citation: Jg. Mchutchison et al., Prednisone withdrawal followed by interferon alpha for treatment of chronic Hepatitis C infection - Results of a randomized controlled trial, J CLIN GAST, 32(2), 2001, pp. 133-137
Authors:
Duchini, A
Younossi, ZM
Saven, A
Bordin, GM
Knowles, HJ
Pockros, PJ
Citation: A. Duchini et al., An open-label pilot trial of cladibrine (2-chlorodeoxyadenosine) in patients with primary sclerosing cholangitis, J CLIN GAST, 31(4), 2000, pp. 292-296
Authors:
Duchini, A
Viernes, ME
Nyberg, LM
Hendry, RM
Pockros, PJ
Citation: A. Duchini et al., Hepatic decompensation in patients with cirrhosis during infection with influenza A, ARCH IN MED, 160(1), 2000, pp. 113-115
Authors:
Pockros, PJ
Bain, VG
Hunter, EB
Conrad, A
Balart, A
Hollinger, FB
Albert, D
Citation: Pj. Pockros et al., A comparison of reverse transcription polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment, J VIRAL HEP, 6(2), 1999, pp. 145-150